Initial sites of SIV rebound after antiretroviral treatment cessation in rhesus macaques.
Saved in:
| Title: | Initial sites of SIV rebound after antiretroviral treatment cessation in rhesus macaques. |
|---|---|
| Authors: | Keele BF; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Okoye AA; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Sciences University, Portland, OR, USA., Immonen TT; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Varco-Merth B; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Sciences University, Portland, OR, USA., Duell D; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Sciences University, Portland, OR, USA., Nkoy C; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Sciences University, Portland, OR, USA., Goodwin W; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Sciences University, Portland, OR, USA., Hoffmeister S; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Sciences University, Portland, OR, USA., Hughes CM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Sciences University, Portland, OR, USA., Kose E; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Conchas A; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Goodman CA; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Fennessey CM; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Macairan A; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Bosche WJ; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Fast R; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Homick CM; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Hull M; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Oswald K; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Shoemaker R; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Silipino L; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Welker JL; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Smedley J; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Sciences University, Portland, OR, USA., Labriola CS; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Sciences University, Portland, OR, USA., Axthelm MK; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Sciences University, Portland, OR, USA., Hansen SG; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Sciences University, Portland, OR, USA., Estes JD; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Sciences University, Portland, OR, USA., Barouch DH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA., Lifson JD; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA. jeffrey.lifson@nih.gov., Picker LJ; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Sciences University, Portland, OR, USA. pickerl@ohsu.edu. |
| Source: | Nature microbiology [Nat Microbiol] 2026 Mar; Vol. 11 (3), pp. 648-663. Date of Electronic Publication: 2026 Jan 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101674869 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2058-5276 (Electronic) Linking ISSN: 20585276 NLM ISO Abbreviation: Nat Microbiol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
